France - English - HMA (Heads of Medicines Agencies)

sogeval - marbofloxacin magnesium salt 100 mg - chewable tablet - dogs non food - marbofloxacin

Germany - English - HMA (Heads of Medicines Agencies)

sogeval - marbofloxacin magnesium salt 100 mg - chewable tablet - dogs non food - marbofloxacin

United States - English - NLM (National Library of Medicine)

mwi - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - fluoroflox chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin - unknown - marbofloxacin antibiotic active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

zyvet animal health inc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetoquinol australia pty ltd - marbofloxacin; clotrimazole; dexamethasone acetate - misc. aural, ophthalmic, oro/naso pharyngeal - marbofloxacin antibiotic active 3.0 mg/ml; clotrimazole imidazole active 10.0 mg/ml; dexamethasone acetate steroid-glucocorticoid active 1.0 mg/ml - ear,nose,throat preps. - dog | bitch | castrate | puppy - otitis externa | acute canine otitis | associated with yeast &/or bac | chronic canine otitis | malassezia pachydermatis | otitis (canine)

United States - English - NLM (National Library of Medicine)

zoetis inc. - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin 25 mg - zeniquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Philippines - English - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - marbofloxacin - solution for injection - 100mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

bridge pharmaceuticals ltd. - marbofloxacin - injection - 10 gm/100 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

bridge pharmaceuticals ltd. - marbofloxacin - bolus - 50 mg